PMID- 28298900
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20191120
IS  - 1664-2392 (Print)
IS  - 1664-2392 (Electronic)
IS  - 1664-2392 (Linking)
VI  - 8
DP  - 2017
TI  - The Impact of Bariatric Surgery on Type 2 Diabetes Mellitus and the Management of 
      Hypoglycemic Events.
PG  - 37
LID - 10.3389/fendo.2017.00037 [doi]
LID - 37
AB  - Recent studies discussed the benefit of bariatric surgery on obese patients 
      diagnosed with type 2 diabetes mellitus (T2DM). Several factors play an essential 
      role in predicting the impact of bariatric surgery on T2DM, such as ABCD score 
      (age, BMI, C-peptide, and duration of the disease), HbA1c, and fasting blood 
      glucose, incretins [glucagon-like peptide-1 (GLP-1) and gastric inhibitory 
      peptide (GIP)]. DiaRem score known to include factors such as age, HbA1c, 
      medication, and insulin usage used to predict the remission of T2DM, but it has 
      some limitations. An extensive literature search was conducted on PubMed and 
      Google Scholar using keywords such as gastric bypass, T2DM, bariatric surgery, 
      GLP-1, GIP, and post bariatric hypoglycemia. Restrictive-malabsorptive procedures 
      are most effective in treating T2DM patients based on changes induced in appetite 
      through regulation of gastrointestinal hormones, with decreased hunger and 
      increased satiation. We provide a review of bariatric surgery influence on T2DM 
      and management of post-intervention hypoglycemic events. Post-bariatric surgery 
      hypoglycemia is a serious complication especially when patients develop 
      life-threatening neuroglycopenia with loss of consciousness and seizure. The 
      avoidance of this adverse event may be achieved by strict dietary modification 
      including a restriction on carbohydrates as well as foods with high glycemic 
      index. Further research will provide more information on post-bariatric surgery 
      hyperinsulinemic hypoglycemia pathophysiology and management.
FAU - Kassem, Mahmoud Attia Mohamed
AU  - Kassem MA
AD  - Department of Anesthesiology, The Ohio State University Wexner Medical Center , 
      Columbus, OH , USA.
FAU - Durda, Michael Andrew
AU  - Durda MA
AD  - Department of Anesthesiology, The Ohio State University Wexner Medical Center , 
      Columbus, OH , USA.
FAU - Stoicea, Nicoleta
AU  - Stoicea N
AD  - Department of Anesthesiology, The Ohio State University Wexner Medical Center , 
      Columbus, OH , USA.
FAU - Cavus, Omer
AU  - Cavus O
AD  - Department of Anesthesiology, The Ohio State University Wexner Medical Center , 
      Columbus, OH , USA.
FAU - Sahin, Levent
AU  - Sahin L
AD  - Department of Anesthesiology, The Ohio State University Wexner Medical Center , 
      Columbus, OH , USA.
FAU - Rogers, Barbara
AU  - Rogers B
AD  - Department of Anesthesiology, The Ohio State University Wexner Medical Center , 
      Columbus, OH , USA.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20170301
PL  - Switzerland
TA  - Front Endocrinol (Lausanne)
JT  - Frontiers in endocrinology
JID - 101555782
PMC - PMC5331470
OTO - NOTNLM
OT  - C-peptide
OT  - Roux-en-Y gastric bypass
OT  - bariatric surgery
OT  - glucagon-like peptide-1
OT  - post-bariatric surgery hypoglycemia
OT  - type 2 DM
EDAT- 2017/03/17 06:00
MHDA- 2017/03/17 06:01
PMCR- 2017/01/01
CRDT- 2017/03/17 06:00
PHST- 2016/12/04 00:00 [received]
PHST- 2017/02/14 00:00 [accepted]
PHST- 2017/03/17 06:00 [entrez]
PHST- 2017/03/17 06:00 [pubmed]
PHST- 2017/03/17 06:01 [medline]
PHST- 2017/01/01 00:00 [pmc-release]
AID - 10.3389/fendo.2017.00037 [doi]
PST - epublish
SO  - Front Endocrinol (Lausanne). 2017 Mar 1;8:37. doi: 10.3389/fendo.2017.00037. 
      eCollection 2017.